CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 38  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.0717
LYS 10.0650
GLU 20.0365
LEU 30.0155
ARG 40.0115
CYS 50.0235
GLN 60.0261
CYS 70.0256
ILE 80.0251
LYS 90.0296
THR 100.0270
TYR 110.0262
SER 120.0207
LYS 130.0289
PRO 140.0171
PHE 150.0101
HIS 160.0231
PRO 170.0144
LYS 180.0057
PHE 190.0131
ILE 200.0069
LYS 210.0098
GLU 220.0074
LEU 230.0119
ARG 240.0231
VAL 250.0206
ILE 260.0170
GLU 270.0251
SER 280.0152
GLY 290.0239
PRO 300.0321
HIS 310.0135
CYS 320.0249
ALA 330.0403
ASN 340.0189
THR 350.0156
GLU 360.0071
ILE 370.0056
ILE 380.0087
VAL 390.0047
LYS 400.0050
LEU 410.0062
SER 420.0110
ASP 430.0183
GLY 440.0083
ARG 450.0046
GLU 460.0030
LEU 470.0117
CYS 480.0142
LEU 490.0165
ASP 500.0204
PRO 510.0220
LYS 520.0189
GLU 530.0089
ASN 540.0343
TRP 550.0052
VAL 560.0127
GLN 570.0188
ARG 580.0177
VAL 590.0045
VAL 600.0012
GLU 610.0087
LYS 620.0127
PHE 630.0185
LEU 640.0286
LYS 650.0239
ARG 660.0410
ALA 670.0551
GLU 680.0267
ASN 690.0717

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.